跳至主要内容
临床试验/NCT04752735
NCT04752735已完成不适用

Endovascular treatmenT for Acute Ischemic Stroke in China: a Retrospective, National, Multi-center, Registry Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年3月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
1
主要终点
Proportion of patients with modified Rankin Score (mRS) 0 to 2

研究概览

简要总结

This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: ≥ 18;
  • Ischemic stroke confirmed by head CT or MRI;
  • Patients receiving endovascular treatment;
  • First ever stroke or mRS≤2 after previous disease;
  • Complete and clear pre- and post-operative DSA images are available

排除标准

  • Imaging data not qualified for evaluation;
  • Absence of important clinical data;
  • The first 50 patients receiving endovascular treatment in a single centerr.

结局指标

主要结局

Proportion of patients with modified Rankin Score (mRS) 0 to 2

时间窗: Day 90

the minimum and maximum values of mRS are 0 and 6, respectively; higher mRS mean a worse outcome

次要结局

  • Proportion of intraparenchymal hemorrhage (PH1 and PH2)(48 hours)
  • Proportion of patients with modified Rankin Score 0 to 2(Day180, 360)
  • Proportion of symptomatic intracranial hemorrhage (sICH)(48 hours)
  • Changes in National Institute of Health stroke scale (NIHSS)(Day 2, 7, 14)
  • Distribution of modified Rankin Score(Day 90, 180, 360)
  • Proportion of death(Day 7)
  • Changes in cerebral edema(48 hours, 7 days)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Head of Neurology

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验